{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-100541","form_type":"8-K","ticker":"ACAD","cik":"0001070494","company_name":"ACADIA PHARMACEUTICALS INC","filed_at":"2022-04-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.621995+00:00","generated_at":"2026-06-26T08:24:46.123507+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Acadia grants retention RSUs to CEO, President, and General Counsel","bullets":["CEO Stephen R. Davis receives 277,331 RSUs; President Srdjan R. Stankovic 144,695 RSUs; EVP Gen. Counsel Austin D. Kim 96,463 RSUs.","RSUs vest: 37.5% at 18 months, 12.5% at 2 years, 25% at 3 years, 25% at 4 years from grant date.","Awards granted under Acadia's 2010 Equity Incentive Plan, with accelerated vesting in certain circumstances."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-100541","json":"https://secwatch.observer/filing/0001193125-22-100541.json","markdown":"https://secwatch.observer/filing/0001193125-22-100541.md","text":"https://secwatch.observer/filing/0001193125-22-100541.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1070494/000119312522100541/0001193125-22-100541-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1070494/000119312522100541/d353045d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T08:24:46.123507+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}